COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 2124: Articles 21231-21240  | Next

Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: a matched cohort study using linked English electronic health records data
Carreira, H., Strongman, H., Peppa, M., McDonald, H. I., dos-Santos-Silva, I., Stanway, S., Smeeth, L., Bhaskaran, K.
10.1101/2020.10.08.20209304 — Posted: 2020-10-12
Level of Knowledge in the COVID-19 Pandemic: A Cross-Sectional Survey of Canadian Medical Students
Niburski, K., Vaughan, R., Papazova, E., Todd, K.
10.1101/2020.10.07.20208801 — Posted: 2020-10-12
One size fits all?: Modeling face-mask fit on population-based faces
Solano, T., Mittal, R., Shoele, K.
10.1101/2020.10.07.20208744 — Posted: 2020-10-12
Clarifying predictions for COVID-19 from testing data: the example of New-York State
Griette, P., Magal, P.
10.1101/2020.10.10.20203034 — Posted: 2020-10-12
Estimated Seroprevalence of SARS-CoV-2 Antibodies Among Adults in Orange County, California
Bruckner, T.-A., Parker, D. M., Bartell, S., Vieira, V., Khan, S., Noymer, A., Drum, E., Albala, B., Zahn, M., Boden-Albala, B.
10.1101/2020.10.07.20208660 — Posted: 2020-10-12 Discussion: Onsite
The effect of salt on the dynamics of CoV-2 RBD at ACE2
Peter, E., Schug, A.
10.1101/2020.10.09.333948 — Posted: 2020-10-12 Discussion: Onsite
Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2
Zhao, D., Xu, W., Zhang, X., Wang, X., Yuan, E., Xiong, Y., Wu, S., Li, S., Wu, N., Tian, T., Feng, X., Shu, H., Lang, P., Shen, X., Li, H., Li, P., Zeng, J.
10.1101/2020.10.09.332734 — Posted: 2020-10-12
SARS-CoV-2-specific peripheral T follicular helper cells correlate with neutralizing antibodies and increase during convalescence.
Boppana, S., Qin, K., Files, J. K., Russell, R. M., Stoltz, R., Bibollet-Ruche, F., Bansal, A., Erdmann, N., Hahn, B. H., Goepfert, P. A.
10.1101/2020.10.07.20208488 — Posted: 2020-10-12
Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana
Andronico, A., Tran Kiem, C., Paireau, J., Succo, T., Bosetti, P., Lefrancq, N., Nacher, M., Djossou, F., Sanna, A., Flamand, C., Salje, H., Rousseau, C., Cauchemez, S.
10.1101/2020.10.07.20208314 — Posted: 2020-10-12
Using test positivity and reported case rates to estimate state-level COVID-19 prevalence in the United States
chiu, W., Ndeffo-Mbah, M. L.
10.1101/2020.10.07.20208504 — Posted: 2020-10-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).